Advocacy Updates


CDC Pink Book Series

CDC is offering a series of weekly one-hour web-on-demand videos that will provide an overview of vaccination principles, general best practices, immunization strategies, and specific information about vaccine-preventable diseases and the vaccines that prevent them. The series will start on July 1, 2020, and a new video will be released most Wednesdays through October 14, … Continue reading “CDC Pink Book Series”


June 2020 NHSN eNewsletter Available

Read about important NHSN updates in the June 2020 issue of the NHSN e-Newsletter. The newsletter includes information on NHSN COVID-19 activities, delay of the release of the Neonatal Component and Late Onset Sepsis and Meningitis Module, updates on the AUR module, and NHSN training updates.


FDA Updates List of Authorized Ventilators under Umbrella EUA

The FDA has updated the list of authorized ventilator, ventilator tubing connector, and ventilator accessory products that meet the criteria for the umbrella emergency use authorization (EUA) to expand availability of ventilators to treat COVID-19 patients. The umbrella EUA was issued in March 2020. Read the EUA and the updated Appendix B list of authorized … Continue reading “FDA Updates List of Authorized Ventilators under Umbrella EUA”


FDA Warns Curativa Bay Corp about Fraudulent COVID-19 Products

The FDA sent a warning letter to Curativa Bay Corporation to cease sale of Advanced Hypochlorous Skin Spray, a topical hypochlorous acid-containing product which is intended to mitigate, prevent, treat, diagnose, or cure COVID-19. FDA reminds consumers that there are currently no FDA-approved products to prevent or treat COVID-19. Read the FDA warning letter.


FDA Letter to HCP and Lab Staff: Stop Using Certain COVID-19 Antibody Tests

The FDA issued a letter to clinical laboratories and healthcare providers recommending that they stop using COVID-19 antibody tests that are listed on FDA’s “removed” test list, found on the FDA’s FAQs on Testing for SARS-CoV-2 webpage.  The “removed” test list includes: tests where significant clinical performance problems were identified that cannot be or have not been … Continue reading “FDA Letter to HCP and Lab Staff: Stop Using Certain COVID-19 Antibody Tests”


CDC Health Advisory: Recent Detection of Resistant Meningococcal Disease

Meningococcal disease, which typically presents as meningitis or meningococcemia, is a life-threatening illness requiring prompt antibiotic treatment for patients and antibiotic prophylaxis for their close contacts. Neisseria meningitidis isolates in the United States have been largely susceptible to the antibiotics recommended for treatment and prophylaxis. However, 11 penicillin- and ciprofloxacin-resistant meningococcal disease cases have been detected in … Continue reading “CDC Health Advisory: Recent Detection of Resistant Meningococcal Disease”


FDA Revokes EUA for Chembio Antibody Test

The FDA revoked the emergency use authorization (EUA) of the Chembio Diagnostic System, Inc. (Chembio) DPP COVID-19 IgM/IgG System, a SARS-CoV-2 antibody test, due to performance concerns with the accuracy of the test. Read the FDA statement.


Webinar June 24: Treating COVID-19

Continuing education units will be available for the webinar, “Learning to Treat COVID-19: Clinical Trials and Developing Therapeutics During a Pandemic.” The webinar, sponsored by the National Academy of Medicine and the American Public Health Association, will discuss how clinicians are learning to treat COVID-19. It will include presentations on how scientists have adapted clinical trials … Continue reading “Webinar June 24: Treating COVID-19”


Joint Commission Resumes Limited Surveys

The Joint Commission (TJC) resumed limited survey activities this month. The primary focus will be on elements of performance related to inspection, testing, and maintenance of equipment and utilities that could raise serious safety concerns during the public health emergency. Read the TJC announcement.